NCT00098527: FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer |
|
|
| Terminated | 2 | 20 | US | romidepsin, FK228, FR901228, Istodax, laboratory biomarker analysis | National Cancer Institute (NCI) | Adenocarcinoma of the Esophagus, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer | 09/05 | | | |
